Literature DB >> 19058198

Hormone escape is associated with genomic instability in a human prostate cancer model.

Marie-Emmanuelle Legrier1, Charlotte Guyader, Jocelyn Céraline, Bernard Dutrillaux, Stéphane Oudard, Marie-France Poupon, Nathalie Auger.   

Abstract

Lack of hormone dependency in prostate cancers is an irreversible event that occurs through generation of genomic instability induced by androgen deprivation. Indeed, the cytogenetic profile of hormone-dependent (HD) prostate cancer remains stable as long as it received a hormone supply, whereas the profile of hormone-independent (HID) variants acquired new and various alterations. This is demonstrated here using a HD xenografted model of a human prostate cancer, PAC120, transplanted for 11 years into male nude mice and 4 HID variants obtained by surgical castration. Cytogenetic analysis, done by karyotype, FISH, CGH and array-CGH, shows that PAC120 at early passage presents numerous chromosomal alterations. Very few additional alterations were found between the 5th and 47th passages, indicating the stability of the parental tumor. HID variants largely maintained the core of chromosomal alterations of PAC120 - losses at 6q, 7p, 12q, 15q and 17q sites. However, each HID variant displayed a number of new alterations, almost all being specific to each variant and very few shared by all. None of the HID had androgen receptor mutations. Our study indicates that hormone castration is responsible for genomic instability generating new cytogenetic abnormalities susceptible to alter the properties of cancer cell associated with tumor progression, such as increased cell survival and ability to metastasize.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19058198     DOI: 10.1002/ijc.24073

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Androgen receptor interacts with telomeric proteins in prostate cancer cells.

Authors:  Sahn-Ho Kim; Michelle Richardson; Kannagi Chinnakannu; V Uma Bai; Mani Menon; Evelyn R Barrack; G Prem-Veer Reddy
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

2.  Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors.

Authors:  Charlotte Guyader; Jocelyn Céraline; Eléonore Gravier; Aurélie Morin; Sandrine Michel; Eva Erdmann; Gonzague de Pinieux; Florence Cabon; Jean-Pierre Bergerat; Marie-France Poupon; Stéphane Oudard
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

3.  Molecular profiling of patient-derived breast cancer xenografts.

Authors:  Fabien Reyal; Charlotte Guyader; Charles Decraene; Carlo Lucchesi; Nathalie Auger; Franck Assayag; Ludmilla De Plater; David Gentien; Marie-France Poupon; Paul Cottu; Patricia De Cremoux; Pierre Gestraud; Anne Vincent-Salomon; Jean-Jacques Fontaine; Sergio Roman-Roman; Olivier Delattre; Didier Decaudin; Elisabetta Marangoni
Journal:  Breast Cancer Res       Date:  2012-01-16       Impact factor: 6.466

4.  Structural and functional association of androgen receptor with telomeres in prostate cancer cells.

Authors:  Junying Zhou; Michelle Richardson; Vidyavathi Reddy; Mani Menon; Evelyn R Barrack; G Prem-Veer Reddy; Sahn-Ho Kim
Journal:  Aging (Albany NY)       Date:  2013-01       Impact factor: 5.682

5.  Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA.

Authors:  Dong Wang; Ivan Garcia-Bassets; Chris Benner; Wenbo Li; Xue Su; Yiming Zhou; Jinsong Qiu; Wen Liu; Minna U Kaikkonen; Kenneth A Ohgi; Christopher K Glass; Michael G Rosenfeld; Xiang-Dong Fu
Journal:  Nature       Date:  2011-05-15       Impact factor: 49.962

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.